Hypothetically if there were enough success in the clinical trials that everyone - the buyer, RAC management, RAC shareholders - can all plainly see that a peak revenue estimate of the usd$44bn number you've projected as a possibility turns out to be not just a possibility but a strong likelihood... What then?
We usually see these buyout multiple of 4-6x peak revenue. What could happen if bisantrene seems almost certain to be worth $44bn per year, since obviously no one can or will pay 5x that much to acquire RAC.
Would shareholders and the board have to accept an offer potentially far below the traditional buyout multiple, as long as it's still at a premium from whatever the share price happens to be?
It's concerning to me that there's no real historical precedent for buyouts above the $20-30bn range, and even those are quite rare. If in the best case scenario bisantrene ends up being worth multiples of that figure, how do we as shareholders ever get to receive that value?
It's like if you live in a quiet country town and want to sell your ferrari, none of the farmers will buy it from you at its fair value because they're not used to paying that much for a car. So what do you do?
- Forums
- ASX - By Stock
- RAC
- Prediction - RAC will have legendary unicorn-like status among drug-development biotechs?
RAC
race oncology ltd
Add to My Watchlist
3.91%
!
$1.20

Prediction - RAC will have legendary unicorn-like status among drug-development biotechs?, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$1.20 |
Change
0.045(3.91%) |
Mkt cap ! $205.8M |
Open | High | Low | Value | Volume |
$1.19 | $1.20 | $1.17 | $53.60K | 45.34K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 20851 | $1.20 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.20 | 121 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20851 | 1.195 |
1 | 6000 | 1.180 |
1 | 1515 | 1.170 |
1 | 7972 | 1.165 |
1 | 256 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.200 | 121 | 2 |
1.210 | 2100 | 1 |
1.220 | 10983 | 2 |
1.235 | 3663 | 1 |
1.260 | 1929 | 1 |
Last trade - 11.54am 02/04/2025 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
AVM
ADVANCE METALS LIMITED
Adam McKinnon, MD
Adam McKinnon
MD
SPONSORED BY The Market Online